Michael Y Ho, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 5
Offices
5 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ho’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A92159 · Current
Licensed to practise in California · since 2005 · expires 2028-10-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,201
Medicare paid this office $3,201 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 64 · 85 and older 0% · Health risk score 3.31. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Chronic kidney disease 67% · Diabetes 61%.
The office billed $20,329, Medicare allowed $4,227 and paid $3,201; for 24 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 24 | 64 | 3.31 | $20,329 | $3,201 |
| 2023 | 16 | 20 | 73 | 2.55 | $8,184 | $1,666 |
| 2022 | 18 | 20 | 70 | 2.09 | $15,002 | $2,769 |
| 2021 | 19 | 26 | 71 | 2.38 | $15,328 | $3,064 |
| 2020 | 15 | 20 | 71 | 4.57 | $11,382 | $2,506 |
| 2019 | 23 | 49 | 73 | 2.95 | $54,805 | $8,581 |
| 2018 | 40 | 66 | 67 | 2.20 | $47,362 | $6,712 |
| 2017 | 24 | 39 | 69 | 2.71 | $28,482 | $4,574 |
| 2016 | 20 | 30 | 68 | 2.44 | $26,906 | $5,871 |
| 2015 | 18 | 20 | 78 | 1.61 | $6,367 | $1,827 |
| 2014 | 28 | 38 | 72 | 1.82 | $24,842 | $5,369 |
| 2013 | 29 | 43 | 76 | 1.93 | $18,449 | $3,211 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $159 | $7 |
2014: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $114 | $7 |
2013: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $158 | $6 |
Medicaid work
$127 in 2023
Medicaid paid $127 for 37 billed services this clinician did in 2023, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 37 | $127 |
| 2023 | 37 | 1 | 20 | $127 |
| 2021 | 13 | 1 | 12 | $120 |
| 2020 | 13 | 1 | 13 | $96 |
| 2018 | 26 | 1 | 13 | $134 |
See the largest Medicaid services in earlier years
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $120 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $96 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $134 |
Drugs they prescribed that Part D paid
$41,782
Pharmacies billed $41,782 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 454) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
402 generic and 52 brand-name prescriptions · $41,782 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Repatha Sureclick | 13 | $7,815 | $601 |
| Pradaxa | 18 | $5,291 | $294 |
| Diltiazem 24hr Er (Cd) | 42 | $1,188 | $28 |
| Metoprolol | 71 | $691 | $10 |
| Lisinopril | 33 | $440 | $13 |
See all 15 drugs
| Repatha Sureclick | 13 | $7,815 | $601 |
| Pradaxa | 18 | $5,291 | $294 |
| Diltiazem 24hr Er (Cd) | 42 | $1,188 | $28 |
| Metoprolol | 71 | $691 | $10 |
| Lisinopril | 33 | $440 | $13 |
| Digoxin | 25 | $379 | $15 |
| Metoprolol | 31 | $362 | $12 |
| Atorvastatin | 21 | $316 | $15 |
| Clopidogrel | 14 | $263 | $19 |
| Furosemide | 24 | $252 | $10 |
| Losartan | 18 | $237 | $13 |
| Nitroglycerin | 17 | $212 | $12 |
| Carvedilol | 13 | $148 | $11 |
| Amlodipine Besylate | 12 | $148 | $12 |
| Isosorbide Mononitrate Er | 12 | $132 | $11 |
Year by year
| 2024 | 454 | 99 | 0% (0) | 11% | $41,782 |
| 2023 | 414 | 90 | 0% (0) | 16% | $34,286 |
| 2022 | 453 | 110 | 0% (0) | 19% | $36,565 |
| 2021 | 480 | 140 | 0% (0) | 12% | $30,016 |
| 2020 | 468 | 127 | 0% (0) | 11% | $24,689 |
| 2019 | 497 | 134 | 0% (0) | 7% | $19,842 |
| 2018 | 570 | 135 | 0% (0) | 24% | $27,245 |
| 2017 | 599 | 139 | 0% (0) | 26% | $31,168 |
| 2016 | 556 | 127 | 0% (0) | None | $25,402 |
| 2015 | 499 | 116 | 0% (0) | 24% | $23,629 |
| 2014 | 394 | 104 | 0% (0) | 19% | $19,460 |
| 2013 | 270 | 68 | 0% (0) | 13% | $11,101 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Pradaxa | 25 | $7,773 | $311 |
| Repatha Sureclick | 13 | $7,525 | $579 |
| Diltiazem 24hr Er (Cd) | 41 | $1,009 | $25 |
| Metoprolol | 71 | $652 | $9 |
| Atorvastatin | 28 | $436 | $16 |
| Metoprolol | 23 | $413 | $18 |
| Lisinopril | 32 | $408 | $13 |
| Amlodipine Besylate | 23 | $276 | $12 |
| Furosemide | 21 | $230 | $11 |
| Carvedilol | 13 | $152 | $12 |
| Losartan | 11 | $130 | $12 |
2022: 14 drugs
| Brilinta | 12 | $7,946 | $662 |
| Pradaxa | 11 | $5,712 | $519 |
| Diltiazem 24hr Er (Cd) | 44 | $1,086 | $25 |
| Metoprolol | 84 | $780 | $9 |
| Clopidogrel | 24 | $447 | $19 |
| Metoprolol | 19 | $393 | $21 |
| Furosemide | 31 | $389 | $13 |
| Atorvastatin | 27 | $376 | $14 |
| Lisinopril | 27 | $337 | $12 |
| Losartan | 18 | $224 | $12 |
| Nitroglycerin | 11 | $223 | $20 |
| Isosorbide Mononitrate Er | 18 | $210 | $12 |
| Carvedilol | 16 | $181 | $11 |
| Amlodipine Besylate | 12 | $139 | $12 |
2021: 12 drugs
| Diltiazem 24hr Er (Xr) | 25 | $1,379 | $55 |
| Metoprolol | 100 | $970 | $10 |
| Clopidogrel | 36 | $713 | $20 |
| Atorvastatin | 35 | $529 | $15 |
| Lisinopril | 32 | $427 | $13 |
| Nitroglycerin | 13 | $424 | $33 |
| Metoprolol | 15 | $408 | $27 |
| Losartan | 22 | $285 | $13 |
| Carvedilol | 22 | $259 | $12 |
| Furosemide | 22 | $255 | $12 |
| Isosorbide Mononitrate Er | 17 | $202 | $12 |
| Amlodipine Besylate | 11 | $124 | $11 |
2020: 12 drugs
| Dilt-Xr | 52 | $4,043 | $78 |
| Flecainide Acetate | 23 | $1,199 | $52 |
| Nitroglycerin | 20 | $952 | $48 |
| Metoprolol | 91 | $854 | $9 |
| Atorvastatin | 40 | $598 | $15 |
| Clopidogrel | 24 | $573 | $24 |
| Lisinopril | 34 | $357 | $10 |
| Carvedilol | 23 | $331 | $14 |
| Furosemide | 27 | $316 | $12 |
| Isosorbide Mononitrate Er | 20 | $240 | $12 |
| Losartan | 16 | $228 | $14 |
| Amlodipine Besylate | 15 | $134 | $9 |
2019: 13 drugs
| Dilt-Xr | 46 | $3,884 | $84 |
| Clopidogrel | 52 | $1,164 | $22 |
| Atorvastatin | 44 | $1,074 | $24 |
| Flecainide Acetate | 18 | $984 | $55 |
| Metoprolol | 107 | $955 | $9 |
| Nitroglycerin | 18 | $541 | $30 |
| Losartan | 31 | $391 | $13 |
| Pantoprazole | 13 | $301 | $23 |
| Lisinopril | 25 | $278 | $11 |
| Carvedilol | 18 | $263 | $15 |
| Isosorbide Mononitrate Er | 22 | $262 | $12 |
| Furosemide | 16 | $179 | $11 |
| Amlodipine Besylate | 17 | $173 | $10 |
2018: 13 drugs
| Pradaxa | 24 | $8,934 | $372 |
| Dilt-Xr | 47 | $2,745 | $58 |
| Atorvastatin | 69 | $1,872 | $27 |
| Flecainide Acetate | 28 | $1,633 | $58 |
| Clopidogrel | 52 | $1,446 | $28 |
| Nitroglycerin | 26 | $1,071 | $41 |
| Metoprolol | 96 | $869 | $9 |
| Pantoprazole | 21 | $567 | $27 |
| Carvedilol | 34 | $419 | $12 |
| Losartan | 25 | $401 | $16 |
| Lisinopril | 28 | $339 | $12 |
| Furosemide | 18 | $202 | $11 |
| Isosorbide Mononitrate Er | 12 | $143 | $12 |
2017: 14 drugs
| Pradaxa | 21 | $9,325 | $444 |
| Clopidogrel | 89 | $2,645 | $30 |
| Dilt-Xr | 47 | $2,596 | $55 |
| Atorvastatin | 74 | $2,145 | $29 |
| Flecainide Acetate | 21 | $1,182 | $56 |
| Nitroglycerin | 34 | $1,028 | $30 |
| Metoprolol | 104 | $928 | $9 |
| Pantoprazole | 20 | $568 | $28 |
| Carvedilol | 35 | $414 | $12 |
| Lisinopril | 33 | $380 | $12 |
| Losartan | 14 | $367 | $26 |
| Furosemide | 15 | $173 | $12 |
| Isosorbide Mononitrate Er | 13 | $166 | $13 |
| Amlodipine Besylate | 11 | $82 | $7 |
2016: 13 drugs
| Pradaxa | 20 | $7,940 | $397 |
| Nitrostat | 34 | $2,734 | $80 |
| Clopidogrel | 71 | $2,539 | $36 |
| Dilt-Xr | 38 | $2,256 | $59 |
| Atorvastatin | 45 | $1,331 | $30 |
| Metoprolol | 99 | $880 | $9 |
| Carvedilol | 49 | $522 | $11 |
| Pantoprazole | 15 | $491 | $33 |
| Lisinopril | 32 | $364 | $11 |
| Hydralazine | 16 | $321 | $20 |
| Losartan | 17 | $289 | $17 |
| Furosemide | 21 | $237 | $11 |
| Atenolol | 17 | $182 | $11 |
2015: 15 drugs
| Pradaxa | 17 | $6,009 | $353 |
| Clopidogrel | 54 | $2,687 | $50 |
| Dilt-Xr | 33 | $2,090 | $63 |
| Nitrostat | 25 | $1,434 | $57 |
| Atorvastatin | 48 | $1,401 | $29 |
| Digoxin | 11 | $1,200 | $109 |
| Flecainide Acetate | 12 | $1,044 | $87 |
| Metoprolol | 102 | $912 | $9 |
| Propafenone | 12 | $714 | $59 |
| Carvedilol | 46 | $448 | $10 |
| Losartan | 15 | $409 | $27 |
| Isosorbide Mononitrate Er | 21 | $249 | $12 |
| Lisinopril | 22 | $232 | $11 |
| Atenolol | 11 | $125 | $11 |
| Furosemide | 12 | $122 | $10 |
2014: 9 drugs
| Dilt-Xr | 31 | $2,077 | $67 |
| Clopidogrel | 42 | $2,006 | $48 |
| Nitrostat | 20 | $1,037 | $52 |
| Propafenone | 14 | $1,021 | $73 |
| Atorvastatin | 25 | $782 | $31 |
| Metoprolol | 85 | $749 | $9 |
| Lisinopril | 30 | $357 | $12 |
| Carvedilol | 23 | $239 | $10 |
| Isosorbide Mononitrate Er | 14 | $201 | $14 |
2013: 6 drugs
| Clopidogrel | 48 | $3,257 | $68 |
| Atorvastatin | 14 | $470 | $34 |
| Metoprolol | 53 | $448 | $8 |
| Simvastatin | 25 | $393 | $16 |
| Amlodipine Besylate | 13 | $285 | $22 |
| Lisinopril | 16 | $175 | $11 |
Money from drug and device companies
$211 in 2025
| 2025 | 2 | 2 | None | $211 |
| 2024 | 2 | 3 | None | $256 |
| 2023 | 1 | 2 | None | $76 |
| 2022 | 2 | 2 | None | $144 |
| 2019 | 1 | 1 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Amplatzer Amulet | $170 | 1 payment
|
| Biotronik | Amvia Edge | $42 | 1 payment
|
See all 2 published payments
| Abbott Laboratories | Meals · 2025-11-12 | Amplatzer Amulet | $170 |
| Biotronik | Meals · 2025-11-07 | Amvia Edge | $42 |
See earlier years (2024, 2023, 2022, 2019)
2024: $256
| Philips North America | (Bs3) Intracardiac Und | $156 | 2 payments
|
| Abbott Laboratories | Ultreon | $100 | 1 payment
|
2023: $76
| Siemens Medical Solutions USA | Magnetom Vida | $76 | 2 payments
|
2022: $144
| Abiomed | Impella | $120 | 1 payment
|
| CVRx | Barostim Neo System | $24 | 1 payment
|
2019: $120
| Corindus | Corpath Grx | $120 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boston Scientific Corporation · Option · 2021 | Their institution | $23,020 |
| Boston Scientific Corporation · Option · 2024 | Their institution | $9,444 |
| BOSTON SCIENTIFIC CORPORATION · Option · 2022 | Their institution | $7,466 |
| Boston Scientific Corporation · Option · 2023 | Their institution | $4,464 |
| Boston Scientific Corporation · Option · 2025 | Their institution | $4,000 |
| Abbott Laboratories · Catalyst Ide Study · 2021 | Their institution | $14 |
Professional record
- NPI
- 1982708988
- Licence
- CA A92159California A92159: Current · expires 2028-10-31
- Trained
- Stanford University School of Medicine, 2004
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- Po Box 19614, Stanford, CA, 94309
- NPI first listed
- 2006-09-11
- NPI last updated
- 2022-02-04
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.